Search
for
Sort by
Research 121–150 of 126
- Impact of androgen deprivation therapy on mortality of prostate cancer patients with COVID-19: a propensity score-based analysis
- Morphogenetic Mechanisms in the Cyclic Regeneration of Hair Follicles and Deer Antlers from Stem Cells
- Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Central precocious puberty secondary to peripheral precocious puberty due to a pineal germ cell tumor: a case and review of literature
- Endocrinology
- The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty
- Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients
- New Methods of Endocrine Management of Prostatic Cancer
- Characteristics of flutamide action on prostatic and testicular functions in the rat
- Chapter 23. Therapeutic Control of Androgen Action
- Incidence of alopecia from endocrine therapies in cancer
- Onychomatricoma with classic features: Case report and review of the literature
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- ANTIANDROGEN THERAPY IN DERMATOLOGY
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Management of Hirsutism
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- Clinical applications of antiandrogens
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Minimal systemic exposure of a new topical triazole antifungal, efinaconazole 10% solution, in patients with severe onychomycosis following 28-day treatment
- 17α-Acetoxy-6-bromo-16β-methylpregna-4,6-diene-3,20-dione
- Effects of Flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat
- Is dehydroepiandrosterone a hormone?
- ANTIANDROGEN AND HORMONAL TREATMENT OF ACNE
- Chapter 17. Selective androgen receptor modulators (SARMs)
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol